Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market is influenced by the rising incidence of orthopedic conditions, including osteoarthritis and fractures, across Europe, the Middle East, and Africa. This demographic shift towards an aging population contributes to a growing demand for orthopedic biomaterials used in joint replacements, spinal surgeries, and other orthopedic procedures.
Technological developments of biomaterials are the prime factors which help in market trends. Advancements in the construction of biocompatible materials including ceramics, polymers and metals are improving functionality and life span of orthopedic implants. This tendency is essential in achieving the growing requirements to extend implant lifespan and functionality.
In EMEA, adoption of minimally invasive orthopedic surgeries is on the rise. This is due to the fact that there are more surgical techniques available as patients look for minimally invasive treatment options with shorter recovery times. There is also a growing demand for biomaterials which support these advanced procedures in surgery. The use of biomaterials that ease minimally invasive procedures is increasing.
The orthopedic implant market is witnessing strong growth with growing number of joint replacement surgeries, spinal procedures and trauma. There is an increasing need for biomaterials capable of performing at a high level and compatible with these implants. In the developed areas of Europe and Middle East, where healthcare infrastructure is well established this trend dominates.
In orthopedics, a significant focus is placed on regenerative medicine which promotes the creation of biomaterials that facilitate tissue restoration and recovery. Biomaterials, including growth factors and stem cells as well as tissue- engineered constructs have received interest for their capability to enhance recovery after orthopedic interventions.
Strategic collaboration and partnerships have been carried out by major players in the EMEA Orthopedic Biomaterial Market. All these alliances between biomaterial manufacturers, medical device companies and research institutions are focused on accelerating innovation in the field of development novel bio-material solutions that will satisfy both an orthopedic surgeon as well as a patient.
The market is influenced by the change towards environmentally friendly and sustainable products, more specifically biodegradable biomaterials. Needless to mention, bioresorbable implants that gradually dissolve in the body reduce patients’ risk of developing new tumors associated with surgical removal.
The orthopedic biomaterial market is faced with changes in their policies and reforms of healthcare systems within the EMEA region. Adoption trends of orthopedic biomaterials are driven by a shift in reimbursement policies, regulatory frameworks and government initiatives that intend to improve the healthcare infrastructure as these factors play an imperative role in shaping market dynamics.
The COVID-19 pandemic has had a multifaceted impact on the orthopedic biomaterial market. While elective surgeries were temporarily halted during certain periods, the resumption of regular healthcare services has led to a rebound in the demand for orthopedic biomaterials. Additionally, the pandemic has highlighted the importance of resilient and adaptable biomaterial solutions in the face of healthcare challenges.
Europe Orthopedic Biomaterial Market Highlights:
Europe, Middle East and Africa Orthopedic Biomaterial Market Overview
Europe Orthopedic Biomaterial Market Size was valued at USD 8.24 Billion in 2023. The Global Europe Orthopedic Biomaterial industry is projected to grow from USD 9.30 Billion in 2024 to USD 24.57 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.08% during the forecast period (2024 - 2032). Biomaterial is acquiring a huge demand for the treatment of different diseases and condition. They have got a special attention in the orthopedic segment. Many different type of implant are prepare by using biomedical.
Increasing aging population is the major driver for the growth of orthopedic market in Europe Middle East and Africa. As this material did not cause any immunological reaction with the body, this makes it as a first choice of preference for manufacturing of the implants. Due to lack of exercise the many different bones and muscle related complication are occurred. This led to increase in the market of orthopedic biomedical in Europe and Middle East and Africa.
Study Objectives of Europe, Middle East and Africa Orthopedic Biomaterial Market information:
- This report gives the complete detail analysis of competitive dynamics.
- To provide the detail information about drivers and factors restraining the market growth.
- Detail information about current opportunities and trend in the market.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to three main geographies and their countries.
- To provide the overview of key players and their strategic profiles in the market and drawing a competitive landscape for the market.
- To provide the market growth map over the forecasted period- 2017-2023.
- To provide the graphs and analyze the market on various factors like- price analysis, supply chain analysis, porters five force analysis etc.
Key Players for Orthopedic Biomaterials Market
Some of the major players in this market are:
- Materion Corporation (US)
- S&V Technologies (Germany)
- Rayner (UK)
- InVision Biomedical (US)
- Royal DSM (Netherlands)
- BASF SE (Germany)
- Carpenter Technology Corporation (US)
- Covestro (Germany)
- Invibio Ltd. (U.K.)
- Ulbrich Stainless Steel & Special Metals, Inc. (US)
- Corbion N.V. (Netherlands)
- CeramTec (Germany)
- Ceradyne (US)
- Heraeus Medical Components (US)
- Kyocera Corporation (Japan)
- Ticona GmbH (Germany)
- Johnson & Johnson (US)
- Osteotech, Inc. (US)
- Cam Bioceramics B.V. (Netherland)
- Evonik Industries AG (Germany)
Orthopedic Biomaterials Market Segmentation
Orthopedic Biomaterials Market is segmented on the basis of, by type of material which is Metals and Non-metals. Metals are further sub segmented into stainless steel, Titanium Alloy, Cobalt alloy and others. Non Metal is sub segmented into Ceramic (Alumina, Calcium Phosphate, Zirconium dioxide. Carbon and Other), Polymeric (Polymethylmethacrylate, Polyethylene, Silicone, Polyester and Other), Natural Biomaterials (Collagen, Chitin & Chitosan and Other) and Others.
On the Basis of application the market is segmented into Joint Replacement, fracture Fixation Devices, Tissue Fixation, Spine implants, Viscosupplementation and Other. Joint replacement is sub segmented into Hip replacement, Knee replacement, Shoulder and elbow replacement and other. Tissue fixation is sub segmented into interference screws, suture anchors and others. Spine implants is further sub segmented into spine fusion, other. Fracture Fixation Devices are sub segmented into Screws, Plates for Bones, Rods and other.
Orthopedic Biomaterials Market Regional Analysis
Europe and Middle East and Africa are the two major region of the market. Europe has the second largest market for orthopedic biomedical globally. Patient with high level of pain in the bones has no option other than joint replacement which improves the quality of life. Germany and UK are invest ample amount of capital in import of the implants. This can serves as an opportunities for the manufacturer to develop the market in this countries. Due to limited infrastructure development Middle East and Africa has a least orthopedic biomedical market.
Market Assessment
The report for Europe, Middle East and Africa Orthopedic Biomaterial Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Intended Audience
- Product manufacturers
- Biomaterial manufacturer
- Research and Development (R&D) Companies
- Hospitals and Laboratories
- Suppliers and distributor of biomaterial.
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
